Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
circadian rhythm
Research
How a ‘clock’ gene could point to new prostate cancer treatments
A study found that CRY1, a gene involved in circadian rhythms, is elevated in advanced prostate cancer—a discovery that could inspire new treatments.
Arlene Weintraub
Jan 15, 2021 9:45am
Targeting the 'clock gene' to slow triple-negative breast cancer
Feb 14, 2020 8:42am
Preventing immune cells from causing heart attacks and strokes
Jan 13, 2020 11:00am
Biogen pays Pfizer $75M for early-phase Alzheimer's drug
Jan 13, 2020 9:30am
Preventing heart failure by altering the circadian clock
Oct 3, 2019 10:45am
